Lila SciencesUnited States
Autonomous science factories
- Version
- LILA
- Cost
- Pricing is not publicly disclosed. Contact Lila Sciences for custom enterprise solutions.
- Model
- LILA
Xaira Therapeutics · #6 most active of 8 in Science & Bio
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Trust score · Mixed
3 data points checked · 2026-09-07
Current version
X-Atlas/Pisces and X-Cell
Entry cost
Enterprise/proprietary drug discovery platform, no public pricing or individual tiers
Changes / 30d
6
The short answers · verified September 12, 2026
Source: Xaira Therapeutics — xaira.com · Reusable under CC BY 4.0 — cite Tomorrow
Enterprise/proprietary drug discovery platform, no public pricing or individual tiers
Entry price over time
Proprietary
Xaira
Context window
—
Public API
no
Multi-model routing
no
Other tracked products running on the same foundation models — a quick read on how much of the catalog moves when one of these models changes.
green disclosed · amber inferred · grey unattributed. Aliases are folded into one model; provider concentration counts only models with an established vendor.
Reference data. Each figure is whatever the source actually said — weekly users, downloads, revenue run-rate — with its own definition and date. These are not comparable between tools and are never used to rank anything.
No public usage figure on record for this product.
Lila SciencesUnited States
Autonomous science factories
Chai DiscoveryUnited States
Antibody and complex design
FutureHouseUnited States
Agents for scientific literature
MITUnited States
Open structure prediction
Altos LabsUnited States
Cellular rejuvenation research
EvolutionaryScaleUnited States
Frontier protein language model
New capabilities: Preclinical Development, Drug Discovery, X-Atlas/Pisces
25 tracked29 tracked · +Preclinical Development, Drug Discovery, X-Atlas/Pisces, X-Cell
sourceNew capabilities: Drug discovery AI, Preclinical development
23 tracked25 tracked · +Drug discovery AI, Preclinical development
sourceNew capabilities: causal biological datasets
22 tracked23 tracked · +causal biological datasets
sourceNew capabilities: Causal biological datasets
20 tracked21 tracked · +Causal biological datasets
sourceNew capabilities: predictive ai models, agentic ai models
17 tracked19 tracked · +predictive ai models, agentic ai models
sourceNew capabilities: Drug discovery and development, Progressable Binders
13 tracked15 tracked · +Drug discovery and development, Progressable Binders
sourceNew capabilities: Predictive AI models, Agentic AI models, Drug discovery
9 tracked13 tracked · +Predictive AI models, Agentic AI models, Drug discovery, Virtual cells
sourceNew capabilities: AI models for drug discovery
7 tracked8 tracked · +AI models for drug discovery
sourceNew capabilities: predictive AI models, agentic AI models, virtual cells
3 tracked7 tracked · +predictive AI models, agentic AI models, virtual cells, drug discovery
sourceNew capabilities: X-Cell virtual cell model, causal perturbation model, drug discovery AI
2 tracked5 tracked · +X-Cell virtual cell model, causal perturbation model, drug discovery AI
sourceNew capabilities: AI drug discovery, computational biology platform
2 tracked4 tracked · +AI drug discovery, computational biology platform
sourceStraight head-to-head pages against the busiest products in Science & Bio.
Free to cite and reuse under CC BY 4.0. Permalink: https://tomorrow.aliensquad.ai/tools/xaira
Tomorrow. (2026). Xaira Therapeutics — version, pricing and model stack [Data set entry]. AlienSquad. Retrieved 2026-09-13, from https://tomorrow.aliensquad.ai/tools/xaira
@misc{tomorrow-tools-xaira,
author = {{Tomorrow}},
title = {Xaira Therapeutics — version, pricing and model stack},
year = {2026},
publisher = {AlienSquad},
howpublished = {\url{https://tomorrow.aliensquad.ai/tools/xaira}},
note = {Accessed: 2026-09-13}
}